Recce Pharmaceuticals Ltd (RCE) - Total Liabilities

Latest as of June 2025: AU$15.47 Million AUD ≈ $10.94 Million USD

Based on the latest financial reports, Recce Pharmaceuticals Ltd (RCE) has total liabilities worth AU$15.47 Million AUD (≈ $10.94 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Recce Pharmaceuticals Ltd to assess how effectively this company generates cash.

Recce Pharmaceuticals Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Recce Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Check RCE asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Recce Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Recce Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
OptiNose NASDAQ:OPTN	USA	$176.22 Million
Alkindo Naratama Tbk JK:ALDO	Indonesia	Rp990.37 Billion
Global Lights Acquisition Corp Ordinary Shares NASDAQ:GLACF	USA	$2.99 Million
GEA Grenobl. Elect. PA:GEA	France	€16.51 Million
Flexopack Société Anonyme Commercial and Industrial Plastics Company AT:FLEXO	Greece	€86.08 Million
Global Lights Acquisition Corp Ordinary Shares NASDAQ:GLAC	USA	$2.99 Million
We & Win Development Co Ltd TW:2537	Taiwan	NT$14.09 Billion
Eimco Elecon (India) Limited NSE:EIMCOELECO	India	Rs507.07 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Recce Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Recce Pharmaceuticals Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.86	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-5.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Recce Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Recce Pharmaceuticals Ltd (2013–2025)

The table below shows the annual total liabilities of Recce Pharmaceuticals Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$15.47 Million ≈ $10.94 Million	-2.69%
2024-06-30	AU$15.89 Million ≈ $11.25 Million	+208.93%
2023-06-30	AU$5.14 Million ≈ $3.64 Million	+100.79%
2022-06-30	AU$2.56 Million ≈ $1.81 Million	+117.54%
2021-06-30	AU$1.18 Million ≈ $833.38K	+26.44%
2020-06-30	AU$931.53K ≈ $659.11K	-29.84%
2019-06-30	AU$1.33 Million ≈ $939.49K	+195.84%
2018-06-30	AU$448.82K ≈ $317.57K	-48.67%
2017-06-30	AU$874.44K ≈ $618.72K	+322.85%
2016-06-30	AU$206.80K ≈ $146.32K	-24.10%
2015-06-30	AU$272.47K ≈ $192.79K	+33.69%
2014-06-30	AU$203.81K ≈ $144.21K	+31.86%
2013-06-30	AU$154.57K ≈ $109.37K	--

About Recce Pharmaceuticals Ltd

AU:RCE Australia Biotechnology

Market Cap

$97.19 Million

AU$137.36 Million AUD

Market Cap Rank

#19299 Global

#634 in Australia

Share Price

AU$0.48

Change (1 day)

+0.00%

52-Week Range

AU$0.28 - AU$0.71

All Time High

AU$1.68